Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation
J Thompson-Coon, M Hoyle, C Green, Z Liu, K Welch, T Moxham, K Stein
Research output: Contribution to journal › Article › peer-review
75
Link opens in a new tab
Citations
(Scopus)
132
Downloads
(Pure)